IMPORTANCE: The Global Burden of Diseases, Injuries, and Risk Factors Study 2019 (GBD 2019) provided systematic estimates of incidence, morbidity, and mortality to inform local and international efforts toward reducing cancer burden. CONCLUSIONS AND RELEVANCE: The results of this systematic analysis suggest that the global burden of cancer is substantial and growing, with burden differing by SDI.
Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.
Read the full paper
Access the original peer-reviewed research via OpenAlex.
| Category | 🧬 Medicine & Biology |
| Published | Dec 30, 2021 |
| Journal | JAMA Oncology |
| Authors | Jonathan Kocarnik, Kelly Compton, Frances Dean, Weijia Fu, Brian Gaw |
| DOI | 10.1001/jamaoncol.2021.6987 |
| Citations | 1,999 |
| Source | OpenAlex |